fifty-five patients with small cell carcinoma of the lung ( sccl ) were treated with alternating courses of cav ( cyclophosphamide , doxorubicin , and vincristine ) and vhm ( etoposide , hexamethylmelamine , and methotrexate ) at 21-day intervals .
C0280599
vhm
C0025677
methotrexate